Overview
Status
Active
Registry date
2018-03-30
Share capital
61,250.00 PLN
Registered address
ul. Szelągowska 24, 61-626 Poznań, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2022, 243 days late), 2 not filed.
- 202526/06/2026
- 2024not filed
- 2023not filed
- 202214/03/2024
- 202111/07/2022
- 202007/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.24kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 9.49kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 4.74kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 237.22kMedianUSD 133.19kAverageUSD 3.03m
Industry
Trademarks
MNM Diagnostics holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Polskie Centrum Biobankowania | Z.511070 | 42, 44 | Protected | Mar 6, 2030 |
| Mark | Protected until | |
|---|---|---|
| Polskie Centrum Biobankowania | Mar 6, 2030 |
Authorized Representatives
Marcin Błaszyk – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mnm Diagnostics, Inc. | 1,225 | $16,545.11 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
2 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Feb 3, 2025 | Bankruptcy proceedings for an entrepreneur | In progress | |
| Jul 14, 2023 | Petition to declare entrepreneur bankruptcy | Closed |
Public aid
7 public aid cases recorded, with a total value of $545,504.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 20, 2022 | Aid for research and development projects: industrial research | $158K$157,977 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| May 20, 2022 | Aid for research and development projects: experimental development | $124.5K$124,459 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,600$3,600 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-18 | Name change (Mnm Diagnostics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji → Mnm Diagnostics Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2023-07-25 | Address change (Ul. Macieja Rataja 64, 61-695, Poznań → Ul. Szelągowska 24, 61-626, Poznań) | |
| 2023-07-25 | Name change (Mnm Diagnostics → Mnm Diagnostics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2023-05-29 | Liquidation opened | |
| 2020-04-09 | Share capital increase (54,000.00 PLN → 61,250.00 PLN) |
FAQ
The company was registered in the Polish National Court Register (KRS) on March 30, 2018.
The headquarters is located at: ul. Szelągowska 24, 61-626 Poznań.
The share capital of the company is PLN 61,250 (approx. $16,545).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
In 2022, the company generated total revenue of $1,407,037, representing a decrease of 13.2% compared to 2021.
No, in 2022 the company was not profitable, reporting a net loss of $167,269. For comparison, in 2021 the loss was $404,439, meaning the company reduced its loss by 52.3%.
The largest operating cost category falls under external services. This category amounted to $680,642 in 2022, representing 46% of all operating expenses.
Last updated: 2026-07-10